<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kerr BA</submitter><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>112456</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7874523</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>399(2)</volume><pubmed_abstract>Identifying patient mutations driving skeletal development disorders has driven our understanding of bone development. Integrin adhesion deficiency disease is caused by a Kindlin-3 (fermitin family member 3) mutation, and its inactivation results in bleeding disorders and osteopenia. In this study, we uncover a role for Kindlin-3 in the differentiation of bone marrow mesenchymal stem cells (BMSCs) down the chondrogenic lineage. Kindlin-3 expression increased with chondrogenic differentiation, similar to RUNX2. BMSCs isolated from a Kindlin-3 deficient patient expressed chondrocyte markers, including SOX9, under basal conditions, which were further enhanced with chondrogenic differentiation. Rescue of integrin activation by a constitutively activated β&lt;sub>3&lt;/sub> integrin construct increas</pubmed_abstract><journal>Experimental cell research</journal><pubmed_title>Kindlin-3 mutation in mesenchymal stem cells results in enhanced chondrogenesis.</pubmed_title><pmcid>PMC7874523</pmcid><funding_grant_id>R01 HL142772</funding_grant_id><funding_grant_id>F32 CA142133</funding_grant_id><funding_grant_id>R01 HL071625</funding_grant_id><funding_grant_id>P01 HL073311</funding_grant_id><funding_grant_id>K99 CA175291</funding_grant_id><pubmed_authors>Kerr BA</pubmed_authors><pubmed_authors>Shi L</pubmed_authors><pubmed_authors>Willey JS</pubmed_authors><pubmed_authors>Caplan AI</pubmed_authors><pubmed_authors>Harris KS</pubmed_authors><pubmed_authors>Byzova TV</pubmed_authors><pubmed_authors>Lennon DP</pubmed_authors><pubmed_authors>Jinnah AH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Kindlin-3 mutation in mesenchymal stem cells results in enhanced chondrogenesis.</name><description>Identifying patient mutations driving skeletal development disorders has driven our understanding of bone development. Integrin adhesion deficiency disease is caused by a Kindlin-3 (fermitin family member 3) mutation, and its inactivation results in bleeding disorders and osteopenia. In this study, we uncover a role for Kindlin-3 in the differentiation of bone marrow mesenchymal stem cells (BMSCs) down the chondrogenic lineage. Kindlin-3 expression increased with chondrogenic differentiation, similar to RUNX2. BMSCs isolated from a Kindlin-3 deficient patient expressed chondrocyte markers, including SOX9, under basal conditions, which were further enhanced with chondrogenic differentiation. Rescue of integrin activation by a constitutively activated β&lt;sub>3&lt;/sub> integrin construct increas</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-03T23:32:22.956Z</modification><creation>2025-04-03T23:32:22.956Z</creation></dates><accession>S-EPMC7874523</accession><cross_references><pubmed>33417921</pubmed><doi>10.1016/j.yexcr.2020.112456</doi></cross_references></HashMap>